PFTC Golf Tournament Raises $30,000 for Prostate Cancer Research

Share Article

The David H. Nickerson Foundation has donated over $30,000 for prostate cancer research to the Siteman Cancer Center, a joint venture between Washington University in St. Louis and Barnes-Jewish Hospital.

Advances in prostate cancer research at Washington University would not be possible without the support of the 2010 Par for the Cure Golf Tournament.

The David H. Nickerson Foundation has donated over $30,000 for prostate cancer research to the Siteman Cancer Center, a joint venture between Washington University in St. Louis and Barnes-Jewish Hospital. The second annual Par For The Cure Shotgun Tee-Off was held on April 16, 2010 at the Four Seasons Resort in Las Colinas—home to the HP Byron Nelson Championship PGA Tour event. The day included a 'longest drive' and 'closest to the pin' competition, a Long Drive Demonstration by two-time National Long Drive Champion, Art Sellinger and an awards ceremony.

According to Steven Cash Nickerson, founder and President of the foundation: “As usual this event takes place a few weeks before the PGA’s Byron Nelson Classic, so the course is in tip top condition—a treat for our participants—and donating to the cause makes this an excellent excuse to play the 18 holes. 2010 was no exception, we had great weather, a great day of golf and we are more than happy to provide much needed research dollars to cure this disease. Next year we have the event set for May 6th and we hope to double the amount.”

Dr. Adam Kibel who specializes in the treatment of urologic cancers at the Siteman Cancer Center and has been recently named Holekamp Family Chair in Urology had this to say: “Advances in prostate cancer research at Washington University would not be possible without the support of the 2010 Par for the Cure Golf Tournament. On behalf of all the patients who benefit from their generosity, I thank Cash Nickerson, the David H. Nickerson Prostate Cancer Foundation, sponsors and players for being our champions. Funding will enable our Siteman Cancer Center researchers to pursue projects ranging from improved screening, to less invasive treatment, to drug trials for patients with advanced prostate cancer. We are attacking prostate cancer on every front. The goal is always the same to decrease the pain and suffering from prostate cancer.”

In addition to donating the proceeds the foundation actively raises awareness about screening and testing. Every man over the age of fifty and at average risk should consider talking to his physician about testing for prostate cancer. They should also actively take part in this decision by learning about prostate cancer and the pros and cons of early detection and treatment. After lung cancer, prostate cancer is the second leading cause of cancer death. One in 6 men will get prostate cancer during his lifetime.

Siteman Cancer Center, parent Institutions Barnes-Jewish Hospital and Washington University School of Medicine are nationally recognized, with U.S. News & World Report magazine consistently ranking both among the best in the country.

To register for upcoming events and/or make a donation please visit http://www.parforthecure.org. To find out more about the foundation visit http://www.davidscure.org.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

COLIN SHUBITZ
Visit website